PT705279E
(pt)
*
|
1993-05-27 |
2003-07-31 |
Selectide Corp |
Bibliotecas em fase solida codificadas, segregadas topologicamente
|
US7597886B2
(en)
*
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US7820798B2
(en)
*
|
1994-11-07 |
2010-10-26 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
US5919897A
(en)
*
|
1995-06-07 |
1999-07-06 |
Torrey Pines Institute For Molecular Studies |
MU opioid receptor ligands: agonists and antagonists
|
AU720632B2
(en)
*
|
1996-03-05 |
2000-06-08 |
Trega Biosciences, Inc. |
Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
|
US6777217B1
(en)
*
|
1996-03-26 |
2004-08-17 |
President And Fellows Of Harvard College |
Histone deacetylases, and uses related thereto
|
CA2264200A1
(en)
|
1996-08-16 |
1998-02-26 |
Human Genome Sciences, Inc. |
Human endokine alpha
|
DK0963377T3
(da)
|
1996-08-30 |
2009-05-18 |
Human Genome Sciences Inc |
Interleukin-19
|
WO1998014569A1
(en)
|
1996-10-02 |
1998-04-09 |
Bloch Donald B |
Leukocyte-specific protein and gene, and methods of use thereof
|
KR20000052796A
(ko)
|
1996-10-25 |
2000-08-25 |
벤슨 로버트 에이치. |
뉴트로킨 알파
|
AU6909098A
(en)
|
1996-10-31 |
1998-05-22 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae polynucleotides and sequences
|
ATE397061T1
(de)
|
1997-01-08 |
2008-06-15 |
Invitrogen Corp |
Verfahren zur herstellung von proteinen
|
US6635443B1
(en)
|
1997-09-17 |
2003-10-21 |
Human Genome Sciences, Inc. |
Polynucleotides encoding a novel interleukin receptor termed interleukin-17 receptor-like protein
|
MXPA00004256A
(es)
|
1997-11-03 |
2005-07-01 |
Human Genome Sciences Inc |
Inhibidor de las celulas endoteliales vasculares, un inhibidor de la angiogenesis y crecimiento del tumor.
|
US6190920B1
(en)
|
1997-11-12 |
2001-02-20 |
The Regents Of The University Of California |
Method for detecting enzyme catalyzed cyclization
|
ATE472599T1
(de)
*
|
1997-11-21 |
2010-07-15 |
Human Genome Sciences Inc |
Chemokin alpha-5
|
CA2323776C
(en)
|
1998-03-19 |
2010-04-27 |
Human Genome Sciences, Inc. |
Cytokine receptor common gamma chain like
|
NZ511629A
(en)
*
|
1998-11-13 |
2004-04-30 |
Pepscan Systems B |
A method for determining a mimotope sequence
|
EP2357192A1
(de)
|
1999-02-26 |
2011-08-17 |
Human Genome Sciences, Inc. |
Menschliches alpha-Endokin und Verfahren zu seiner Verwendung
|
EP1265641A2
(de)
|
2000-02-22 |
2002-12-18 |
Biostream, Inc. |
Bilderzeugende mitteln zur diagnose von parkinson's krankheit
|
US20030129724A1
(en)
*
|
2000-03-03 |
2003-07-10 |
Grozinger Christina M. |
Class II human histone deacetylases, and uses related thereto
|
US7550425B2
(en)
*
|
2000-06-16 |
2009-06-23 |
Zealand Pharma A/S |
Diuretic peptide conjugates
|
WO2002013848A1
(en)
*
|
2000-08-11 |
2002-02-21 |
Invitrogen Corporation |
Highly homogeneous molecular markers for electrophoresis
|
US7323327B2
(en)
|
2001-02-23 |
2008-01-29 |
Dsm Ip Assets B.V. |
Genes encoding novel proteolytic enzymes
|
ATE497603T1
(de)
|
2001-03-02 |
2011-02-15 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
WO2002070020A2
(en)
|
2001-03-02 |
2002-09-12 |
University Of Western Ontario |
Polymer precursors of radiolabeled compounds, and methods of making and using the same
|
DE60236646D1
(de)
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 Antikörper
|
US7244853B2
(en)
|
2001-05-09 |
2007-07-17 |
President And Fellows Of Harvard College |
Dioxanes and uses thereof
|
US8802618B2
(en)
*
|
2002-03-08 |
2014-08-12 |
Board Of Regents, The University Of Texas System |
Controlled modulation of amino acid side chain length of peptide antigens
|
ES2559764T3
(es)
|
2002-03-11 |
2016-02-15 |
Molecular Insight Pharmaceuticals, Inc. |
Complejos de tecnecio-dipiridina, y métodos de uso de los mismos
|
ATE476500T1
(de)
*
|
2002-05-21 |
2010-08-15 |
Dsm Ip Assets Bv |
Neue phospholipasen und deren verwendungen
|
AU2003270088A1
(en)
|
2002-08-19 |
2004-03-11 |
Dsm Ip Assets B.V. |
Novel lipases and uses thereof
|
AU2003296326A1
(en)
|
2002-12-09 |
2004-06-30 |
Massachusetts Institute Of Technology |
Ligands for metals and improved metal-catalyzed processes based thereon
|
US8435492B2
(en)
*
|
2003-05-02 |
2013-05-07 |
University Of Western Ontario |
Prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals
|
CN102138869B
(zh)
|
2003-09-08 |
2013-05-01 |
纳幕尔杜邦公司 |
基于肽的用于毛发、皮肤和指甲的调理剂和着色剂
|
US20050226839A1
(en)
*
|
2003-09-08 |
2005-10-13 |
Xueying Huang |
Pepetide-based body surface reagents for personal care
|
US7807141B2
(en)
|
2003-09-08 |
2010-10-05 |
E.I. Du Pont De Nemours And Company |
Peptide-based oral care surface reagents for personal care
|
US7285264B2
(en)
*
|
2003-09-08 |
2007-10-23 |
E.I. Du Pont De Nemours And Company |
Peptide-based body surface coloring reagents
|
US20100311641A1
(en)
*
|
2003-09-08 |
2010-12-09 |
E. I. Du Pont De Nemours And Company |
Peptide-based body surface coloring reagents
|
US7309482B2
(en)
*
|
2003-09-08 |
2007-12-18 |
E.I. Du Pont De Nemours And Company |
Long lasting waterproof sunscreen comprising metal oxide and peptide conditioner
|
US7585495B2
(en)
|
2003-09-08 |
2009-09-08 |
E. I. Du Pont De Nemours And Company |
Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom
|
US7220405B2
(en)
*
|
2003-09-08 |
2007-05-22 |
E. I. Du Pont De Nemours And Company |
Peptide-based conditioners and colorants for hair, skin, and nails
|
EP2388017B1
(de)
|
2004-02-24 |
2014-12-24 |
The General Hospital Corporation |
Katalytische Radiofluorierung
|
US20050261474A1
(en)
*
|
2004-05-20 |
2005-11-24 |
Mixture Sciences, Inc. |
Method of support-based chemical synthesis
|
US20070264277A1
(en)
|
2004-07-22 |
2007-11-15 |
Dirk Behrens |
Compositions and Methods of Use for Mgd-Csf in Disease Treatment
|
UA90502C2
(ru)
*
|
2005-02-18 |
2010-05-11 |
Сьёрфейс Лоджикс, Инк. |
Имидазотриазиноновые соединения и фармацевтическая композиция, которая их содержит
|
UA95604C2
(ru)
*
|
2005-02-18 |
2011-08-25 |
Сьёрфейс Лоджикс, Инк. |
Способ регулирования фармакокинетического и/или фармакодинамического свойства соединения
|
WO2006094267A2
(en)
*
|
2005-03-03 |
2006-09-08 |
Indiana University Research And Technology Corporation |
Permethylation of oligosaccharides
|
CA2937005A1
(en)
|
2005-03-22 |
2006-09-28 |
President And Fellows Of Harvard College |
Treatment of protein degradation disorders
|
US8945573B2
(en)
|
2005-09-08 |
2015-02-03 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Targeted identification of immunogenic peptides
|
US20070065387A1
(en)
*
|
2005-09-16 |
2007-03-22 |
Beck William A |
Method for enhancing the effect of particulate benefit agents
|
US7736633B2
(en)
|
2005-09-28 |
2010-06-15 |
E.I. Du Pont De Nemours And Company |
Method for enhancing effects of colorants and conditioners
|
US7700716B2
(en)
*
|
2005-12-15 |
2010-04-20 |
E. I. Du Pont De Nemours And Company |
Polytetrafluoroethylene binding peptides and methods of use
|
US7858581B2
(en)
*
|
2005-12-15 |
2010-12-28 |
E. I. Du Pont De Nemours And Company |
PMMA binding peptides and methods of use
|
US7632919B2
(en)
*
|
2005-12-15 |
2009-12-15 |
E.I. Du Pont De Nemours And Company |
Polystyrene binding peptides and methods of use
|
US7928076B2
(en)
*
|
2005-12-15 |
2011-04-19 |
E. I. Du Pont De Nemours And Company |
Polypropylene binding peptides and methods of use
|
US7906617B2
(en)
|
2005-12-15 |
2011-03-15 |
E. I. Du Pont De Nemours And Company |
Polyethylene binding peptides and methods of use
|
US7709601B2
(en)
*
|
2005-12-15 |
2010-05-04 |
E. I. Du Pont De Nemours And Company |
Nylon binding peptides and methods of use
|
EP3936621A1
(de)
|
2006-01-20 |
2022-01-12 |
Cell Signaling Technology, Inc. |
Translokation und mutante ros-kinase in humanem nichtkleinzelligem bronchialkarzinom
|
US20120208824A1
(en)
|
2006-01-20 |
2012-08-16 |
Cell Signaling Technology, Inc. |
ROS Kinase in Lung Cancer
|
AU2007214458C1
(en)
|
2006-02-14 |
2012-12-06 |
Dana-Farber Cancer Institute, Inc. |
Histone deacetylase inhibitors
|
WO2008091349A1
(en)
*
|
2006-02-14 |
2008-07-31 |
The President And Fellows Of Harvard College |
Bifunctional histone deacetylase inhibitors
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
EP3266867A1
(de)
|
2006-04-14 |
2018-01-10 |
Cell Signaling Technology, Inc. |
Gendefekte und mutante alk-kinase in festen menschlichen tumoren
|
JP5497431B2
(ja)
|
2006-05-03 |
2014-05-21 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ヒストンデアセチラーゼおよびチューブリンデアセチラーゼ阻害剤
|
BRPI0716571A2
(pt)
|
2006-08-24 |
2013-11-05 |
Surface Logix Inc |
Compostos farmacocineticamente otimizados
|
US7732569B2
(en)
|
2006-10-19 |
2010-06-08 |
E.I. Du Pont De Nemours And Company |
Zein-based peptide tags for the expression and purification of bioactive peptides
|
US7662913B2
(en)
|
2006-10-19 |
2010-02-16 |
E. I. Du Pont De Nemours And Company |
Cystatin-based peptide tags for the expression and purification of bioactive peptides
|
US20100234568A1
(en)
*
|
2006-10-19 |
2010-09-16 |
Linda Jane Decarolis |
Identification of peptide tags for the production of insoluble peptides by sequence scanning
|
JP2010511637A
(ja)
*
|
2006-12-06 |
2010-04-15 |
南▲開▼大学 |
ポリペプチド系重合体およびその合成方法
|
WO2008100596A2
(en)
*
|
2007-02-15 |
2008-08-21 |
Burnham Institute For Medical Research |
Biomarkers of neurodegenerative disease
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US7678883B2
(en)
*
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
CA2695505A1
(en)
|
2007-08-06 |
2009-02-12 |
Burnham Institute For Medical Research |
Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency
|
CA2702686C
(en)
|
2007-10-18 |
2023-04-04 |
Cell Signaling Technology, Inc. |
Translocation and mutant ros kinase in human non-small cell lung carcinoma
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
CA2731730C
(en)
*
|
2008-07-23 |
2017-06-13 |
President And Fellows Of Harvard College |
Deacetylase inhibitors and uses thereof
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158822A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
PT2881402T
(pt)
|
2009-02-12 |
2017-08-23 |
Cell Signaling Technology Inc |
Expressão de ros mutante em cancro de fígado humano
|
US8481678B2
(en)
|
2009-03-30 |
2013-07-09 |
E I Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
BRPI1014677A2
(pt)
|
2009-03-30 |
2016-04-12 |
Du Pont |
sistemas baseados em peptídeos para distribuição de agentes cosméticos
|
EP2995303A1
(de)
*
|
2009-07-10 |
2016-03-16 |
President and Fellows of Harvard College |
Permanent geladene natrium- und calciumkanalblocker als entzündungshemmende mittel
|
WO2011019393A2
(en)
|
2009-08-11 |
2011-02-17 |
President And Fellows Of Harvard College |
Class- and isoform-specific hdac inhibitors and uses thereof
|
NZ750559A
(en)
|
2009-08-27 |
2023-01-27 |
Pastoral Greenhouse Gas Res Ltd |
Complete genome sequence of the methanogen methanobrevibacter ruminantium
|
US20120101108A1
(en)
|
2010-08-06 |
2012-04-26 |
Cell Signaling Technology, Inc. |
Anaplastic Lymphoma Kinase In Kidney Cancer
|
EP3336181B1
(de)
|
2012-04-18 |
2022-01-12 |
Cell Signaling Technology, Inc. |
Egfr und ros1 bei krebs
|
US10155987B2
(en)
|
2012-06-12 |
2018-12-18 |
Dana-Farber Cancer Institute, Inc. |
Methods of predicting resistance to JAK inhibitor therapy
|
US11021443B2
(en)
|
2015-08-03 |
2021-06-01 |
President And Fellows Of Harvard College |
Charged ion channel blockers and methods for use
|
JP2022527690A
(ja)
|
2019-03-11 |
2022-06-03 |
ノシオン セラピューティクス,インコーポレイテッド |
荷電したイオンチャンネル遮断薬および使用方法
|
US10786485B1
(en)
|
2019-03-11 |
2020-09-29 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
US10780083B1
(en)
|
2019-03-11 |
2020-09-22 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
BR112021017809A2
(pt)
|
2019-03-11 |
2021-11-23 |
Nocion Therapeutics Inc |
Bloqueadores de canais iônicos substituídos por éster e métodos para uso
|
WO2020185881A1
(en)
|
2019-03-11 |
2020-09-17 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2021091585A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
WO2021091586A1
(en)
|
2019-11-06 |
2021-05-14 |
Nocion Therapeutics, Inc. |
Charged ion channel blockers and methods for use
|
MX2022011194A
(es)
|
2020-03-11 |
2022-11-08 |
Nocion Therapeutics Inc |
Bloqueadores de canales ionicos cargados y metodos de uso.
|